Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1Cognitive Dysfunction 1Brain Neoplasms 1

Interventions

Transcranial Direct Current Stimulation 2Exercise 2mazdutide 1lime 1fasudil 1enzalutamide 1Time 1Tablets 1Standard of Care 1Referral and Consultation 1Ramipril 1Radiosurgery 1Prednisone 1Population Groups 1Palliative Care 1Organization and Administration 1Modafinil 1Methods 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Low-Level Light Therapy 1Hormones 1Health 1Gonadotropin-Releasing Hormone 1Electroencephalography 1Drug Delivery Systems 1Data Collection 1Anesthesia, General 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Ramipril × 1 year × Clear all
NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Wake Forest University Health Sciences

Phase 2 Completed
75 enrolled 47 charts
CNS

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡